Skip to main content

Advertisement

SpringerLink
Log in

Defects in the Leukocyte Adhesion Cascade

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Leukocyte trafficking from bloodstream to tissue is important for the continuous surveillance for foreign antigens as well as for rapid leukocyte accumulation at sites of inflammatory response or tissue injury. Leukocyte interaction with vascular endothelial cells is a pivotal event in the inflammatory response and is mediated by several families of adhesion molecules. The crucial role of the β2-integrin subfamily in leukocyte emigration was established after leukocyte adhesion deficiency (LAD) I was discovered. Patients with this disorder suffer from life-threatening bacterial infections, and in its severe form, death usually occurs in early childhood unless bone marrow transplantation is performed. The LAD II disorder clarifies the role of the selectin receptors and their fucosylated ligands. Clinically, patients with LAD II suffer not only from a less severe form of infectious episodes resembling the moderate phenotype of LAD I but also from severe psychomotor and growth retardation. LAD III emphasizes the importance of the integrin-activation phase in the adhesion cascade. All hematopoietic integrin activation processes are defective, which lead to severe infection as observed in LAD I and to marked increase tendency for bleeding problems (defective activation of β1, β2, and β3 integrins). The various genetic defects leading to all adhesion molecules syndrome will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84(7):2068–2101

    CAS  PubMed  Google Scholar 

  2. Luster AD, Alon R, von Andrian UH (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6(12):1182–1190

    Article  CAS  PubMed  Google Scholar 

  3. Abram CL, Lowell CA (2009) The ins and outs of leukocyte integrin signaling. Ann Rev Immunol 27:339–362

    Article  CAS  Google Scholar 

  4. Shamri R, Grabovsky V, Gauguet JM, Feigelson S, Manevich E, Kolanus W, Robinson MK, Staunton DE, von Andrian UH, Alon R (2005) Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol 6(5):497–506

    Article  CAS  PubMed  Google Scholar 

  5. Pasvolsky R, Feigelson SW, Kilic SS et al (2007) A LADIII syndrome is associated with effective expression of the Rap-1 activator alDAG-GEF1 in lymphocyte, neutrophils and platelets. J Exp Med 204(7):1571–1582

    CAS  PubMed  Google Scholar 

  6. Anderson DC, Smith CW (2001) Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited diseases, 7th edn. McGraw-Hill, New York, pp 3955–3995

    Google Scholar 

  7. Etzioni A (1996) Adhesion molecules-their role in health and disease. Pediatr Res 39(2):191–198

    Article  CAS  PubMed  Google Scholar 

  8. Fischer A, Lisowska-Grospierre B, Anderson DC, Springer T (1988) Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunol Rev 1(1):39–54

    CAS  Google Scholar 

  9. von Adrian UH, Berger EM, Ramezani L, Chambers JD et al (1993) In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J Clin Invest 91(6):2893–2897

    Article  Google Scholar 

  10. Hogg N, Stewart MP, Scarth SL, Newton R, Shaw JM, Law SK, Klein N (1999) A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest 103(1):97–106

    Article  CAS  PubMed  Google Scholar 

  11. Roos D, Meischl C, de Boer M, Simsek S, Weening RS, Sanal O et al (2002) Genetic analysis of patients with leukocyte adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations. Exp Hemat 30(3):252–261

    Article  CAS  PubMed  Google Scholar 

  12. Tone Y, Wada T, Shibata F, Toma T, Kasahara Y, Koizumi S, Yachie A (2007) Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood 109(3):1182–1184

    Article  CAS  PubMed  Google Scholar 

  13. Uzel G, Ing E, Rosenzweig SD, Hsu AP et al (2008) Reversion mutations in patients with leukocyte adhesion deficiency type 1 (LAD-1). Blood 111(1):209–218

    Article  CAS  PubMed  Google Scholar 

  14. Lorusso F, Kong D, Jalil AK, Sylvestre C, Tan SL, Ao A (2006) Preimplantation genetic diagnosis of leukocyte adhesion deficiency type I. Fertil Steril 85(2):e415–e498

    Article  Google Scholar 

  15. Thomas C, Le Deist F, Cavazzana-Calvo M, Benkerrou M, Haddad E, Blanche S, Hartmann W, Friedrich W, Fischer A (1995) Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 86(4):1629–1635

    CAS  PubMed  Google Scholar 

  16. Bauer TR, Hickstein DD (2000) Gene therapy for leukocyte adhesion deficiency. Curr Opin Mol Ther 2(4):383–388

    CAS  PubMed  Google Scholar 

  17. Bauer TR, Allen JM, Hai M, Tuschong LM et al (2008) Successful treatment of canine leukocyte adhesive deficiency by foamy virus vectors. Nat Med 14(1):93–97

    Article  CAS  PubMed  Google Scholar 

  18. Etzioni A, Frydman M, Pollack S, Avidor I et al (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327(25):1789–1792

    Article  CAS  PubMed  Google Scholar 

  19. Yakubenia S, Wild MK (2006) Leukocyte adhesion deficiency II. Advances and open questions. FEBS J 273(19):4390–4398

    Article  CAS  PubMed  Google Scholar 

  20. Wild MK, John K, Marquardt T, Vestweber D (2002) Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs 172(3):161–173

    Article  CAS  PubMed  Google Scholar 

  21. Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N (1998) Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol 102(2):323–324

    Article  CAS  PubMed  Google Scholar 

  22. Karsan A, Cornejo CJ, Winn RK, Schwartz BR, Way W, Lannir N, Gershoni-Baruch R, Etzioni A, Ochs HD, Harlan JM (1998) Leukocyte adhesion deficiency type II is a generalized defect of de novo GDP- fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium. J Clin Invest 101(11):2438–2445

    Article  CAS  PubMed  Google Scholar 

  23. Lubke T, Marquardt T, von Figura K, Korner C (1999) A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the Golgi. J Biol Chem 274(1):25986–25989

    Article  CAS  PubMed  Google Scholar 

  24. Lubke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Korner C (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet 28(1):73–76

    Article  CAS  PubMed  Google Scholar 

  25. Helmus Y, Denecke J, Yakubenia S, Robinson P et al (2006) Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood 107(10):3959–3966

    Article  CAS  PubMed  Google Scholar 

  26. Hellbrush CC, Sperandis M, Frommhold D et al (2007) Golgi GDP-fucose transporter deficient mice mimic congenital disorder of glycozylation IIc/leukocyte adhesion deficiency II. J Biol Chem 282(14):10762–10772

    Article  CAS  Google Scholar 

  27. Sturla L, Rampal R, Haltiwanger RS, Fruscione F, Etzioni A, Ronetti M (2003) Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in LAD II (CDG IIc). J Biol Chem 278(29):21559–21565

    Article  PubMed  CAS  Google Scholar 

  28. Luo Y, Haltiwanger RS (2005) O-fucosylation on Notch occur in the endoplasmic reticulum. J Biol Chem 280(12):11289–11294

    Article  CAS  PubMed  Google Scholar 

  29. Marquardt T, Luhn K, Srikrishna G, Freeze HH, Harms E, Vestweber D (1999) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94(12):3976–3985

    CAS  PubMed  Google Scholar 

  30. Etzioni A, Tonetti M (2000) Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95(11):3641–3643

    CAS  PubMed  Google Scholar 

  31. Alon R, Aker M, Feigelson S, Sokolovsky-Eisenberg M, Staunton DE, Cinamon G, Grabovsky V, Shamri R, Etzioni A (2003) A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 101(11):4437–4445

    Article  CAS  PubMed  Google Scholar 

  32. Alon R, Etzioni A (2003) LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol 24(10):561–566

    Article  CAS  PubMed  Google Scholar 

  33. Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, Verhoeven AJ, Roos D (1997) Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta 2 integrins. J Clin Invest 100(7):1725–1733

    Article  CAS  PubMed  Google Scholar 

  34. Harris ES, Shigeoka AO, Li W, Adams RH, Prescott SM, McIntyre TM, Zimmerman GA, Lorant DE (2001) A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins. Blood 97(3):767–776

    Article  CAS  PubMed  Google Scholar 

  35. MacDowall A, Inwald D, Leitinger B, Jones A, Leisner R, Klein N, Hogg N (2003) A novel form of intregrin dysfunction involving beta 1, beta2 and beta 3 integrins. J Clin Invest 111(1):51–60

    Google Scholar 

  36. Kinashi T, Aker M, Sokolovsky-Eisenberg M, Grabovsky V, Tanaka C, Shamri R, Feigelson S, Etzioni A, Alon R (2004) LAD III, a leukocyte adhesion deficiency syndrome associated with defective Rap-1 activation and impaired stabilization of integrin bonds. Blood 103(3):1033–1036

    Article  CAS  PubMed  Google Scholar 

  37. Bos JL, de Rooij J, Reedquist KA (2001) Rap-1 signalling: adhering to new models. Nat Rev Mol Cell Biol 2(5):369–377

    Article  CAS  PubMed  Google Scholar 

  38. Crittenden JR, Bergmeier W, Zhang Y, Piffath CL et al (2004) CalDAG-GEFI integrates signalling for platelet aggregation and thrombus formation. Nat Med 10(9):982–986

    Article  CAS  PubMed  Google Scholar 

  39. Bergmeier W, George T, Wang HW et al (2007) Mice Lacking the signalling molecule CalDAG-GEF1 represent a model for leukocyte adhesion deficiency type III. JCI 117(6):1699–1707

    Article  CAS  PubMed  Google Scholar 

  40. Mory A, Feigelson SW, Yarali N (2008) Kindlin-3 a new gene involved in the pathogenesis of LAD III. Blood 112(6):2591

    Article  CAS  PubMed  Google Scholar 

  41. Kuijpers TW, van de Vijver E, Weternman MAJ et al (2009) LAD-1/variant syndrome is caused by mutations in FERMT3. Blood, in press. doi:10.1182/blood-2008-10-182154

  42. Larjava H, Plow EF, Wu C (2008) Kindlines: essential regulators of integrin signalling and cell-matrix adhesion. EMBO 9(12):1203–1208

    Article  CAS  Google Scholar 

  43. Moser M, Bauer M, Schmid S et al (2009) Kindlin 3 is required for beta 2 integrin mediated leukocyte Adhesion to endothelial cells. Nat Med 15(3):300–305

    Article  CAS  PubMed  Google Scholar 

  44. Svensson L, Howarth K, McDowall A et al (2009) Leukocyte adhesion deficiency III is caused by Mutations in Kindlin # affecting integrin activation. Nat Med 15(3):306–312

    Article  CAS  PubMed  Google Scholar 

  45. Malinin NI, Zhang L, Choi J et al (2009) A point mutation in Kindlin 3 ablates activation of three Subfamilies in humans. Nat Med 15(3):313–318

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Meyer Children Hospital, Rappaport School of Medicine, Technion, Haifa, Israel

    Amos Etzioni

Authors
  1. Amos Etzioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amos Etzioni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Etzioni, A. Defects in the Leukocyte Adhesion Cascade. Clinic Rev Allerg Immunol 38, 54–60 (2010). https://doi.org/10.1007/s12016-009-8132-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-009-8132-3

Keywords

Search

Navigation